Actionable insights straight to your inbox

Equities logo

DJIA, S&P 500 Slip as NASDAQ Falls Amid Corporate Earnings

The nonchalance of Carl Icahn in his Tuesday evening CNBC interview, as he was handed and then proceeded to sip on a martini, was of no solace to investors in Wednesday’s trading session, as
Markets were up across the board with all the major indices reporting gains on a slew of better-than-expected earnings reports from several key players, as well as some other major positive
Aldeyra Therapeutics ($ALDX) is a biotechnology company focused primarily on the development of products to treat immune-mediated, inflammatory, orphan, and other diseases that are thought to be
The full IPO calendar is available at IPOpremium. Scheduled IPOs are ranked by IPO size. Almost $5 billion in scheduled new offerings. (1) Based in Detroit, MI, Ally Financial ($ALLY) scheduled a